![](/img/cover-not-exists.png)
Tu1846 PHASE 2A PROOF OF CONCEPT PLACEBO CONTROLLED STUDY WITH ORAL ABX464 50MG QD IN ULCERATIVE COLITIS SHOWS ENDOSCOPIC IMPROVEMENT WITH LOSS OF MICROSCOPIC DISEASE ACTIVITY IN MOST ENDOSCOPIC RESPONDERS
De Hertogh, Gert, Steens, Jean-Marc, Santo, Julien, Gineste, Paul, Vermeire, SeverineVolume:
158
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(20)33633-7
Date:
May, 2020
File:
PDF, 353 KB
2020